SWStonkWhisper
← Back to Intel
Insider ActivityZVRA

Bode John B, Director at ZEVRA THERAPEUTICS, INC., traded $195K of ZVRA

Last updated Aug 12, 2026

This page documents an SEC Form 4 insider trading disclosure for $ZVRA securities filed with the Securities and Exchange Commission. Section 16 of the Securities Exchange Act of 1934 mandates that corporate officers, directors, and beneficial owners of more than 10% of a company's registered equity securities must report their personal trades within two business days of execution. Insider transactions are closely monitored by market participants because insiders possess firsthand knowledge of company operations, financial condition, and near-term prospects. The transaction details below are drawn directly from the SEC EDGAR filing database and reflect the information as reported.

Bode John B Director
ZEVRA THERAPEUTICS, INC. · $ZVRA
$195K Total Value
39,200 Shares Traded
$4.97 Price / Share
84,200 Shares Owned After
2026-03-26 Filing Date

Transaction Details

InsiderBode John B
TitleDirector
CompanyZEVRA THERAPEUTICS, INC.
TickerZVRA
Transaction TypeExercise
Transaction Date2026-03-24
Shares Traded39,200
Price Per Share$4.97
Total Value$195K
Filed Date2026-03-26
Accession Number0001612084-26-000002

Ownership Context

Shares Owned After Transaction84,200
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001612084-26-000002

Other Insider Trades — ZVRA

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for ZVRA — ZEVRA THERAPEUTICS, INC. →

Whisper Score — ZVRA

68.07
Frenzy
Current Whisper Score

See full analysis for ZVRA →

Track ZVRA insider activity in real time on The Wire →

Get alerts when Bode John B files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: August 12, 2026 at 07:43 UTC

Not Financial Advice: This article is for informational and educational purposes only and does not constitute financial advice, investment advice, or a recommendation to buy or sell any security. StonkWhisper aggregates publicly available data from verified regulatory filings and proprietary analysis pipelines. All investment decisions are made solely at your own risk. Guerilla Finance LLC is not a registered investment advisor or broker-dealer. Always consult a qualified financial professional before making investment decisions.

Want real-time data? Access The Wire for live sentiment tracking.